Nurse Practitioner, Family · Findlay, OH
NPI
1164945697
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3949 N Main St
Findlay, OH, 45840
Phone (419) 423-3888
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
992 services
Medicare patients, 2024
337
Average age 78
Drug cost, 2024
$773K
3,252 prescriptions
Company payments, 2025
$334
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emilie Scarbrough was code 99214 (office e&m - established), 705 times for 305 patients. In total Emilie Scarbrough billed 992 services in 12 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-07-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 705 | 305 | $73.18 | $52K |
| 99215 Office E&M - Established | Office | 74 | 73 | $102.73 | $7,602 |
| J1939 Injection, bumetanide, 0.5 mg | Office | 56 | 19 | $0.50 | $27.73 |
| 96374 Injection Administration | Office | 25 | 21 | $20.86 | $521 |
| 93000 Electrocardiogram | Office | 23 | 21 | $8.70 | $200 |
By year: 2022 $40K for 696 services; 2023 $57K for 787 services; 2024 $63K for 992 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 13 | 11 | $7.84 | $102 |
Medicare prescription drug claims, 2024
In 2024, the drug Emilie Scarbrough prescribed most often to Medicare patients was Potassium Chloride, with 499 prescriptions and refills. In total Emilie Scarbrough wrote 3,252 Medicare prescriptions that cost $773K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Potassium Chloride Generic | 499 | 1,196 | 187 | $15K |
| Bumetanide Generic | 455 | 1,166 | 164 | $21K |
| Furosemide Generic | 382 | 983 | 128 | $2,137 |
| Entresto Sacubitril/Valsartan | 269 | 594 | 79 | $372K |
| Metoprolol Succinate Generic | 250 | 632 | 90 | $3,534 |
| Spironolactone Generic | 199 | 490 | 69 | $1,527 |
| Farxiga Dapagliflozin Propanediol | 133 | 298 | 44 | $163K |
| Metolazone Generic | 130 | 188 | 69 | $844 |
| Jardiance Empagliflozin | 89 | 204 | 30 | $116K |
| Hydralazine Hcl Generic | 81 | 205 | 28 | $1,082 |
| Klor-Con M20 Potassium Chloride | 76 | 216 | 34 | $1,969 |
| Metoprolol Tartrate Generic | 74 | 216 | 29 | $945 |
| Lisinopril Generic | 67 | 193 | 31 | $553 |
| Carvedilol Generic | 58 | 172 | 26 | $454 |
| Losartan Potassium Generic | 53 | 147 | 19 | $337 |
Brand drugs: 676 claims; generic drugs: 2,576 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emilie Scarbrough $334 ($334 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abiomed with $143.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.